On the other hand, during NASH, NK cells are recruited into the liver via mechanisms including chemokine (C-X-C motif) ligand 10 (CXCL10) (43), where they have an antifibrotic effect (37, 43, 44, 70–74). The gene discussed is CXCL10; the disease is metabolic dysfunction-associated steatohepatitis.